ונקומיצין ויאטריס 500 מג

Country: Israel

Language: Hebrew

Source: Ministry of Health

Active ingredient:

VANCOMYCIN AS HYDROCHLORIDE

Available from:

GENMEDIX , ISRAEL

ATC code:

A07AA09

Pharmaceutical form:

LYOPHILIZED POWDER FOR INJECTION

Composition:

VANCOMYCIN AS HYDROCHLORIDE 500 MG/VIAL

Administration route:

תוך-ורידי, פומי

Prescription type:

מרשם נדרש

Manufactured by:

VIATRIS SANTE, FRANCE

Therapeutic group:

VANCOMYCIN

Therapeutic area:

VANCOMYCIN

Therapeutic indications:

Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci. It is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs.Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal

Authorization date:

2021-10-31